Results
|
|
2021.
|
|
|
|
2022.
|
|
|
|
2023.
|
|
|
|
2024.
|
|
|
|
2025.
|
|
|
|
2026.
|
|
|
|
2027.
|
|
|
|
2028.
|
|
|
|
2029.
|
|
|
|
2030.
|
|
|
|
2031.
|
|
|
|
2032.
|
|
|
|
2033.
|
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. [electronic resource] by
- Cole, K E
- Strick, C A
- Paradis, T J
- Ogborne, K T
- Loetscher, M
- Gladue, R P
- Lin, W
- Boyd, J G
- Moser, B
- Wood, D E
- Sahagan, B G
- Neote, K
Producer: 19980707
In:
The Journal of experimental medicine vol. 187
Availability: No items available.
|
|
|
2034.
|
|
|
|
2035.
|
|
|
|
2036.
|
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial. [electronic resource] by
- Essell, J H
- Schroeder, M T
- Harman, G S
- Halvorson, R
- Lew, V
- Callander, N
- Snyder, M
- Lewis, S K
- Allerton, J P
- Thompson, J M
Producer: 19980610
In:
Annals of internal medicine vol. 128
Availability: No items available.
|
|
|
2037.
|
|
|
|
2038.
|
|
|
|
2039.
|
|
|
|
2040.
|
|